Nama Insights

Global X Genomics & Biotechnology ETF (GNOM)

Health · Global X Funds · NASDAQ

HealthETF
Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund in the Health category. It has $91.90M in assets, an expense ratio of 0.50% and a 1.01% dividend yield. The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Assets under management$91.90M
Expense ratio0.50%
CategoryHealth
Dividend yield1.01%
NAV$66.45
Fund familyGlobal X Funds
ExchangeNASDAQ

Top holdings

The largest positions Global X Genomics & Biotechnology ETF reports, by weight.

HoldingNameWeight
MRNA Moderna Inc 7.50%
TWST Twist Bioscience Corp 6.34%
TXG 10x Genomics Inc Ordinary Shares - Class A 5.48%
GH Guardant Health Inc 5.28%
ILMN Illumina Inc 4.86%
NTRA Natera Inc 4.60%
1548.HK Genscript Biotech Corp Class H 3.81%
VRTX Vertex Pharmaceuticals Inc 3.70%
TECH Bio-Techne Corp 3.67%
BMRN BioMarin Pharmaceutical Inc 3.58%

Other Health ETFs

Explore live GNOM data on Nama Insights →